Table of Content

1. Preface
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: U.S. Pruritus Treatment Market

4. Market Overview
    4.1. Overview
    4.2. Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunities
    4.3. U.S. Pruritus Treatment Market Analysis and Forecast, 2017-2031
        4.3.1. Market Revenue Projections (US$ Mn)
        4.3.2. Market Volume Projections (Thousand Units)

5. Key Insights
    5.1. Porter’s Five Forces Analysis
    5.2. Disease Prevalence & Incidence Rate
    5.3. Pricing Analysis
    5.4. Overview and Application of OTC Products in Treatment of Pruritus
    5.5. COVID-19 Impact Analysis

6. U.S. Pruritus Treatment Market Analysis and Forecast, by Pruritus Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Pruritus Type, 2017-2031
        6.3.1. Systemic Diseases
            6.3.1.1. Cancer
            6.3.1.2. Liver Disease
            6.3.1.3. Kidney Disease
            6.3.1.4. Others
        6.3.2. Skin Diseases
            6.3.2.1. Eczema
            6.3.2.2. Atopic Dermatitis
            6.3.2.3. Others
        6.3.3. Neurologic Diseases
            6.3.3.1. Shingles
            6.3.3.2. Multiple Sclerosis
            6.3.3.3. Others
        6.3.4. Nocturnal Pruritus
        6.3.5. Pruritus Ani
        6.3.6. Others
    6.4. Market Attractiveness Analysis, by Pruritus Type

7. U.S. Pruritus Treatment Market Analysis and Forecast, by Drug Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value & Volume Forecast, by Drug Type, 2017-2031
        7.3.1. Antihistamines
        7.3.2. Calcineurin Inhibitors
        7.3.3. Selective Serotonin Reuptake Inhibitors
        7.3.4. Corticosteroids
        7.3.5. Calamine
        7.3.6. Neuroleptics
        7.3.7. Others
    7.4. Market Attractiveness Analysis, by Drug Type

8. U.S. Pruritus Treatment Market Analysis and Forecast, by Sales Type
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value & Volume Forecast, by Sales Type, 2017 - 2031
        8.3.1. Rx Sales
        8.3.2. OTC Sales
    8.4. Market Attractiveness Analysis, by Sales Type

9. U.S. Pruritus Treatment Market Analysis and Forecast, by Dosage Form
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value & Volume Forecast, by Dosage Form, 2017-2031
        9.3.1. Topical
        9.3.2. Oral
    9.4. Market Attractiveness Analysis, by Dosages Form

10. U.S. Pruritus Treatment Market Analysis and Forecast, by Distribution Channel
    10.1. Introduction & Definition
    10.2. Key Findings/Developments
    10.3. Market Value Forecast, by Distribution Channel, 2017-2031
        10.3.1. Hospital Pharmacies
        10.3.2. Retail Pharmacies
        10.3.3. Online Pharmacies
    10.4. Market Attractiveness Analysis, by Distribution Channel

11. Competition Landscape
    11.1. Market Player - Competition Matrix (by tier and size of companies)
    11.2. Market Share Analysis, by Company, 2021
    11.3. Company Profiles
        11.3.1. AbbVie, Inc. (Allergan plc)
            11.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.1.2. Test Type Portfolio
            11.3.1.3. Financial Overview
            11.3.1.4. SWOT Analysis
            11.3.1.5. Strategic Overview
        11.3.2. Albireo Pharma, Inc.
            11.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.2.2. Test Type Portfolio
            11.3.2.3. Financial Overview
            11.3.2.4. SWOT Analysis
            11.3.2.5. Strategic Overview
        11.3.3. Astellas Pharma, Inc.
            11.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.3.2. Test Type Portfolio
            11.3.3.3. Financial Overview
            11.3.3.4. SWOT Analysis
            11.3.3.5. Strategic Overview
        11.3.4. Cipla Limited
            11.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.4.2. Test Type Portfolio
            11.3.4.3. Financial Overview
            11.3.4.4. SWOT Analysis
            11.3.4.5. Strategic Overview
        11.3.5. Eli Lilly and Company
            11.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.5.2. Test Type Portfolio
            11.3.5.3. Financial Overview
            11.3.5.4. SWOT Analysis
            11.3.5.5. Strategic Overview
        11.3.6. GSK plc
            11.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.6.2. Test Type Portfolio
            11.3.6.3. Financial Overview
            11.3.6.4. SWOT Analysis
            11.3.6.5. Strategic Overview
        11.3.7. Merck & Co., Inc.
            11.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.7.2. Test Type Portfolio
            11.3.7.3. Financial Overview
            11.3.7.4. SWOT Analysis
            11.3.7.5. Strategic Overview
        11.3.8. Pfizer, Inc.
            11.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.8.2. Test Type Portfolio
            11.3.8.3. Financial Overview
            11.3.8.4. SWOT Analysis
            11.3.8.5. Strategic Overview
        11.3.9. Teva Pharmaceutical Industries Ltd.
            11.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.9.2. Test Type Portfolio
            11.3.9.3. Financial Overview
            11.3.9.4. SWOT Analysis
            11.3.9.5. Strategic Overview
        11.3.10. Viatris Inc. (Mylan N.V.)
            11.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            11.3.10.2. Test Type Portfolio
            11.3.10.3. Financial Overview
            11.3.10.4. SWOT Analysis
            11.3.10.5. Strategic Overview



List of Figures

List of Figures

Figure 01: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, 2017-2031

Figure 03: U.S. Pruritus Treatment Market Value Share, by Pruritus Type, 2022

Figure 04: U.S. Pruritus Treatment Market Value Share, by Drug Type, 2022

Figure 05: U.S. Pruritus Treatment Market Value Share, by Sales Type, 2022

Figure 06: U.S. Pruritus Treatment Market Value Share, by Dosage Form, 2022

Figure 07: U.S. Pruritus Treatment Market Value Share, by Distribution Channel, 2022

Figure 08: U.S. Pruritus Treatment Market Value Share Analysis, by Pruritus Type, 2022 and 2031

Figure 09: U.S. Pruritus Treatment Market Attractiveness Analysis, by Pruritus Type, 2023-2031

Figure 10: U.S. Pruritus Treatment Market (US$ Mn), by Systemic Diseases, 2017-2031

Figure 11: U.S. Pruritus Treatment Market (US$ Mn), by Skin Diseases, 2017-2031

Figure 12: U.S. Pruritus Treatment Market (US$ Mn), by Neurologic Diseases, 2017-2031

Figure 13: U.S. Pruritus Treatment Market (US$ Mn), by Nocturnal Pruritus, 2017-2031

Figure 14: U.S. Pruritus Treatment Market (US$ Mn), by Pruritus Ani, 2017-2031

Figure 15: U.S. Pruritus Treatment Market (US$ Mn), by Nocturnal Pruritus, 2017-2031

Figure 16: U.S. Pruritus Treatment Market Value Share Analysis, by Drug Type, 2022 and 2031

Figure 17: U.S. Pruritus Treatment Market Attractiveness Analysis, by Drug Type, 2023-2031

Figure 18: U.S. Pruritus Treatment Market (US$ Mn), by Antihistamines, 2017-2031

Figure 19: U.S. Pruritus Treatment Market (US$ Mn), by Calcineurin Inhibitors, 2017-2031

Figure 20: U.S. Pruritus Treatment Market (US$ Mn), by Selective Serotonin Reuptake Inhibitors, 2017-2031

Figure 21: U.S. Pruritus Treatment Market (US$ Mn), by Corticosteroids, 2017-2031

Figure 22: U.S. Pruritus Treatment Market (US$ Mn), by Calamine, 2017-2031

Figure 23: U.S. Pruritus Treatment Market (US$ Mn), by Corticosteroids, 2017-2031

Figure 24: U.S. Pruritus Treatment Market (US$ Mn), by Others, 2017-2031

Figure 25: U.S. Pruritus Treatment Market Value Share Analysis, by Sales Type, 2022 and 2031

Figure 26: U.S. Pruritus Treatment Market Attractiveness Analysis, by Sales Type, 2023-2031

Figure 27: U.S. Pruritus Treatment Market (US$ Mn), by Rx Sales, 2017-2031

Figure 28: U.S. Pruritus Treatment Market (US$ Mn), by OTC Sales, 2017-2031

Figure 29: U.S. Pruritus Treatment Market Value Share Analysis, by Dosage Form, 2022 and 2031

Figure 30: U.S. Pruritus Treatment Market Attractiveness Analysis, by Dosage Form, 2023-2031

Figure 31: U.S. Pruritus Treatment Market (US$ Mn), by Topical, 2017-2031

Figure 32: U.S. Pruritus Treatment Market (US$ Mn), by Oral, 2017-2031

Figure 33: U.S. Pruritus Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 34: U.S. Pruritus Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Figure 35: U.S. Pruritus Treatment Market (US$ Mn), by Hospital Pharmacies, 2017-2031

Figure 36: U.S. Pruritus Treatment Market (US$ Mn), by Retail Pharmacies, 2017-2031

Figure 37: U.S. Pruritus Treatment Market (US$ Mn), by Online Pharmacies, 2017-2031

Figure 38: U.S. Pruritus Treatment Market Share Analysis, by Company, 2022

List of Tables

List of Tables

Table 01: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Pruritus Type, 2017-2031

Table 02: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Systemic Diseases, 2017-2031

Table 03: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Skin Diseases, 2017-2031

Table 04: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Neurologic Diseases, 2017-2031

Table 05: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031

Table 06: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, by Drug Type, 2017-2031

Table 07: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Sales Type, 2017-2031

Table 08: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, by Sales Type, 2017-2031

Table 09: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031

Table 10: U.S. Pruritus Treatment Market Volume (Thousand Units) Forecast, by Dosage Form, 2017-2031

Table 11: U.S. Pruritus Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031